NNM Securities

COMPANY
more from company profile
HomeMarket Info Company Profile Smart Quotes

Smart Quotes

THEMIS MEDICARE LTD.

NSE : THEMISMEDBSE : 530199ISIN CODE : INE083B01024Industry : Pharmaceuticals & DrugsHouse : Private
BSE210.850.95 (+0.45 %)
PREV CLOSE ( ) 209.90
OPEN PRICE ( ) 209.85
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 7178
TODAY'S LOW / HIGH ( )205.80 211.50
52 WK LOW / HIGH ( )131.34 266
NSE210.150.65 (+0.31 %)
PREV CLOSE( ) 209.50
OPEN PRICE ( ) 210.60
BID PRICE (QTY) 210.15 (40)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 21124
TODAY'S LOW / HIGH( ) 208.00 211.65
52 WK LOW / HIGH ( )132.6 263.85
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 31-05 1969
Management Info
Dinesh S Patel - Chairman Sachin D Patel - Managing Director
Registered Office

Address Plot No 69 A,G I D C Industrial Estate, ,
Vapi,
Gujarat-396195

Phone 0260-2431447/ 2430219

Email themis@themismedicare.com

Website www.themismedicare.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS
16Apr Themis Medicare informs about complian
Themis Medicare has informed that it enclosed the Compliance Certificate..
08Apr Themis Medicare informs about certific
Themis Medicare has informed that it enclosed a Certificate under Regula..
12Mar Themis Medicare informs about newspape
In terms of Regulation 47 of the SEBI Listing Regulations, Themis Medica..
10Nov Themis Medicare launches novel Opioid
Themis Medicare has launched a novel Opioid Injectable Analgesic Remifen..
06Nov Themis Medicare informs about newspape
In terms of Regulations 47 of the SEBI Listing Regulations, Themis Medic..
MORE
Financials
Rs. in Millions
QTR Dec 23 ANNUAL 23
Net Profit20.01432.94
Gross Profit 28.52 589.08
Operating Profit 86.33789.67
Net Sales 825.133543.23
MORE
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Dr. Reddy's Lab (BSE)
 6217.15 (4.47%)
M.Cap (Rs. in Cr)103713.42
Abbott India (BSE)
 25725.00 (1.03%)
M.Cap (Rs. in Cr)54663.83
Bharat Parenterals (BSE)
 1701.80 (10.00%)
M.Cap (Rs. in Cr)990.39
Alkem Laboratories (BSE)
 4857.90 (3.10%)
M.Cap (Rs. in Cr)58083.48
NGL Fine-Chem (BSE)
 2711.85 (3.47%)
M.Cap (Rs. in Cr)1675.39
MORE
Shareholding Pattern
PROMOTERS 67.15%
NON-INSTITUTION 32.81%
FI/BANKS/INSURANCE 0.01%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%
MORE
Mf Holdings
Scheme NameHold(%)
Motilal Oswal S&P B...0.07
MORE
ATTENTION INVESTORSKYCIPO
TERMS & CONDITIONS| PRIVACY POLICY| REFUND & CANCELLATION POLICY| DISCLAIMER| DISCLOSURE| KMP DETAILS | CDSL e-Voting | SEBI| FMC| NSE| BSE| MCX | SCORES
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
Assamese Bengali Gujrati Hindi Kanada
Kashmiri Konkani Malyalam Marathi Oriya
Punjabi Sindhi Tamil Telegu Urdu
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016|SEBI-PMS: INP000007100|LEI- 3358007DLCFNHY8J2F96

Filing compliant on SCORES – Easy & quick

  • Register on SCORES portal
  • Mandatory details for filing complaints on SCORES:
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • Benefits:
    • i.) Effective communication
    • ii.) Speedy redressal of the grievances
SMART ODR Portal
INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Copyright © 2021 NNM Securities.com

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.